Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Couillard

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Chest|March 9, 2024
Climate Change and Inhaler Selection in Patients With Respiratory DiseaseSamir Gupta, Simon Couillard, Geneviève Digby, et al.
Thorax|August 7, 2021
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxideSimon Couillard, Annette Laugerud, Maisha Jabeen, et al.
Respirology (Carlton, Vic.)|May 20, 2022
Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) frameworkSimon Couillard, Ian D Pavord, Liam G Heaney, et al.
Chest|October 7, 2023
Are We Ready for Asthma Remission as a Clinical Outcome?Njira L Lugogo, Arjun Mohan, Praveen Akuthota, et al.
ERJ Open Research|February 10, 2022
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)Simon Couillard, William Il Hoon Do, Richard Beasley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2025
"Treat-to-Target": A Call for Earlier Targeted Intervention in AsthmaSimon Couillard, Ian Pavord, Flavia Hoyte, et al.
Respiratory Medicine|April 30, 2025
Neuromodulation of dyspnea - A literature reviewSandrine Massé, Joël St-Pierre, Tommy Delisle, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, CanadaThomas G Poder, Nathalie Carrier, Maryse Bélanger, et al.
Expert Review of Respiratory Medicine|July 12, 2024
Type 2 severe asthma: pathophysiology and treatment with biologicsCorrado Pelaia, James Melhorn, Timothy Sc Hinks, et al.
The Lancet. Respiratory Medicine|July 20, 2025
Breathing barriers: bridging lung health, research, and awarenessHendrik Pott, Dominic L Sykes, Jeremy Charriot, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Chest|March 9, 2024
Climate Change and Inhaler Selection in Patients With Respiratory DiseaseSamir Gupta, Simon Couillard, Geneviève Digby, et al.
Thorax|August 7, 2021
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxideSimon Couillard, Annette Laugerud, Maisha Jabeen, et al.
Respirology (Carlton, Vic.)|May 20, 2022
Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) frameworkSimon Couillard, Ian D Pavord, Liam G Heaney, et al.
Chest|October 7, 2023
Are We Ready for Asthma Remission as a Clinical Outcome?Njira L Lugogo, Arjun Mohan, Praveen Akuthota, et al.
ERJ Open Research|February 10, 2022
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)Simon Couillard, William Il Hoon Do, Richard Beasley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2025
"Treat-to-Target": A Call for Earlier Targeted Intervention in AsthmaSimon Couillard, Ian Pavord, Flavia Hoyte, et al.
Respiratory Medicine|April 30, 2025
Neuromodulation of dyspnea - A literature reviewSandrine Massé, Joël St-Pierre, Tommy Delisle, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 24, 2018
Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, CanadaThomas G Poder, Nathalie Carrier, Maryse Bélanger, et al.
Expert Review of Respiratory Medicine|July 12, 2024
Type 2 severe asthma: pathophysiology and treatment with biologicsCorrado Pelaia, James Melhorn, Timothy Sc Hinks, et al.
The Lancet. Respiratory Medicine|July 20, 2025
Breathing barriers: bridging lung health, research, and awarenessHendrik Pott, Dominic L Sykes, Jeremy Charriot, et al.
Pageof 7